68 related articles for article (PubMed ID: 2945353)
1. Urinary urokinase-converting protease and its comparison with plasmin.
Hayashi S; Yamada K
Nihon Ketsueki Gakkai Zasshi; 1986 Jul; 49(4):995-8. PubMed ID: 2945353
[No Abstract] [Full Text] [Related]
2. [Enzymatic fibrinolytic agents].
Jamet M; Granthil C; Levy G
Ann Anesthesiol Fr; 1978; 19(8):693-6. PubMed ID: 31112
[TBL] [Abstract][Full Text] [Related]
3. Stimulation by heparin of the plasmin-mediated conversion of single-chain to two-chain urokinase-type plasminogen activator.
Lijnen HR; Collen D
Thromb Res; 1986 Sep; 43(6):687-90. PubMed ID: 2945283
[No Abstract] [Full Text] [Related]
4. Plasmin, substilisin-like endoproteases, tissue plasminogen activator, and urokinase plasminogen activator are involved in activation of latent TGF-beta 1 in human seminal plasma.
Chu TM; Kawinski E
Biochem Biophys Res Commun; 1998 Dec; 253(1):128-34. PubMed ID: 9875232
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic modulation of thrombopoietin activity: comparison of thrombin, plasmin, and urokinase.
Reiner AP; Aramaki KM
Thromb Haemost; 2000 Jun; 83(6):909-14. PubMed ID: 10896248
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic enzymes in proliferation and neoplastic metastases formation.
Gołaszewski Z; Gacko M; Chyczewska E; Chyczewski L; Myćko G; Worowski K
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():48-59. PubMed ID: 9337523
[TBL] [Abstract][Full Text] [Related]
7. Presence of urokinase-converting protease in the cultured medium of human kidney cells.
Hayashi S; Yamada K
Nihon Ketsueki Gakkai Zasshi; 1988 Feb; 51(1):130-6. PubMed ID: 3164558
[No Abstract] [Full Text] [Related]
8. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
Wells JM; Strickland S
J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
[TBL] [Abstract][Full Text] [Related]
9. On the conversion of high molecular weight urokinase to the low molecular weight form by plasmin.
Barlow GH; Francis CW; Marder VJ
Thromb Res; 1981 Sep; 23(6):541-7. PubMed ID: 6459663
[No Abstract] [Full Text] [Related]
10. Inhibitory effect of amidino-substituted heterocyclic compounds on the amidase activity of plasmin and of high and low molecular weight urokinase and on urokinase-induced plasminogen activation.
Geratz JD; Shaver SR; Tidwell RR
Thromb Res; 1981 Oct 1-15; 24(1-2):73-83. PubMed ID: 6460342
[No Abstract] [Full Text] [Related]
11. Molecular mechanisms of protease-mediated tumor invasiveness.
Blasi F
J Surg Oncol Suppl; 1993; 3():21-3. PubMed ID: 8503981
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of fibrinolytic enzymes in vivo.
Ambrus JL; Weber FJ; Ambrus CM
J Med; 1979; 10(1-2):99-119. PubMed ID: 158624
[TBL] [Abstract][Full Text] [Related]
13. Enhanced activation of prourokinase by human RC2A leukemia cells.
Tapiovaara H; Vaheri A; Alitalo R; Sim PS; Woodrow G; Stephens RW
Semin Thromb Hemost; 1991 Jul; 17(3):251-61. PubMed ID: 1665587
[No Abstract] [Full Text] [Related]
14. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
15. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
Yomtova VM; Stambolieva NA; Blagoev BM
Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
[TBL] [Abstract][Full Text] [Related]
16. [Different reactivity of UK- and SK-activated plasmin against two fluorogenic substrates for plasmin (author's transl)].
Suzuki K; Nishioka J; Hashimoto S
Nihon Ketsueki Gakkai Zasshi; 1981 May; 44(3):690-8. PubMed ID: 6460414
[No Abstract] [Full Text] [Related]
17. Effects of Pseudomonas fluorescens M3/6 bacterial protease on plasmin system and plasminogen activation.
Frohbieter KA; Ismail B; Nielsen SS; Hayes KD
J Dairy Sci; 2005 Oct; 88(10):3392-401. PubMed ID: 16162512
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activators and plasmin in lung cancer.
Maksimowicz T; Gacko M; Chyczewska E; Chyczewski L; Myćko G; Worowski K
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():72-8. PubMed ID: 9337525
[TBL] [Abstract][Full Text] [Related]
19. Proteolysis and cell migration: creating a path?
Murphy G; Gavrilovic J
Curr Opin Cell Biol; 1999 Oct; 11(5):614-21. PubMed ID: 10508651
[TBL] [Abstract][Full Text] [Related]
20. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
Odekon LE; Blasi F; Rifkin DB
J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
